Total Views : 803
.
NDA cCep – Drug Price Control in India: A Regulatory Perspective
About Video
Uploaded on 1 June, 2020
May 22, 2020 (21:00 – 22:00 IST)
Speakers: Dr. Milind Antani, Gowree Gokhale, Darren Punnen
Kanchana TK- Director- Government affairs, Market Access, Healthcare Affairs, Institutional business Boehringer Ingelheim
MK Narayanswami – former Senior Director – Accounting and Taxation Sanofi India Limited
Currently associated as Consultant to Sanofi India and OPPI
To be our Premium Guest,
Please Register
Length : 01:07:16
Category: homepage, NDA cCep, and Public.
Featured Videos
-
26:05
Digital Twin Distribution – Bridging Virtual Replicas and the Law (November 05, 2024)
Speaker: Aaron
-
05:30
“Investment return is not enough” Nishith Desai with Nikunj Dalmia (ET Now) at FII8 event in Riyadh
Speaker: Nishith
-
Unmasking Deepfakes – Dr. Nishith Desai
Speaker: Nishith
-
42:01
Analysing SEBI’s Consultation Paper on Simplification of registration for FPIs (September 26, 2024)
Speaker: Prakhar Dua Ritul